Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Events

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All patients who has experienced cardiovascular events

Exclusion criteria

Patients with no cardiovascular events.

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Jul 15, 2011
Registry last updated: Aug 30, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed